Treatment of manic or mixed episodes of up to moderate severity in patients with bipolar disorder and schizoaffective disorder. Non-interventional prospective cohort study (NIS) with Zeldox [ziprasidone]

Trial Profile

Treatment of manic or mixed episodes of up to moderate severity in patients with bipolar disorder and schizoaffective disorder. Non-interventional prospective cohort study (NIS) with Zeldox [ziprasidone]

Completed
Phase of Trial: Phase IV

Latest Information Update: 08 Jul 2015

At a glance

  • Drugs Ziprasidone (Primary)
  • Indications Bipolar I disorders; Bipolar II disorders; Schizoaffective disorder
  • Focus Therapeutic Use
  • Sponsors Pfizer
  • Most Recent Events

    • 11 Jan 2008 Status changed from in progress to completed.
    • 17 Sep 2007 Status changed from initiated to in progress.
    • 14 Jun 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top